Publication
Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure
dc.contributor.author | Gjini, Erida | |
dc.contributor.author | Gomes, M. Gabriela M. | |
dc.date.accessioned | 2016-03-21T13:34:54Z | |
dc.date.available | 2016-03-21T13:34:54Z | |
dc.date.issued | 2016-03 | |
dc.description.abstract | The efficacy of vaccines is typically estimated prior to implementation, on the basis of randomized controlled trials. This does not preclude, however, subsequent assessment post-licensure, while mass-immunization and nonlinear transmission feedbacks are in place. In this paper we show how cross-sectional prevalence data post-vaccination can be interpreted in terms of pathogen transmission processes and vaccine parameters, using a dynamic epidemiological model. We advocate the use of such frameworks for model-based vaccine evaluation in the field, fitting trajectories of cross-sectional prevalence of pathogen strains before and after intervention. Using SI and SIS models, we illustrate how prevalence ratios in vaccinated and non-vaccinated hosts depend on true vaccine efficacy, the absolute and relative strength of competition between target and non-target strains, the time post follow-up, and transmission intensity. We argue that a mechanistic approach should be added to vaccine efficacy estimation against multi-type pathogens, because it naturally accounts for inter-strain competition and indirect effects, leading to a robust measure of individual protection per contact. Our study calls for systematic attention to epidemiological feedbacks when interpreting population level impact. At a broader level, our parameter estimation procedure provides a promising proof of principle for a generalizable framework to infer vaccine efficacy post-licensure. | pt_PT |
dc.description.sponsorship | sem patrocinadores explícitos no artigo. | pt_PT |
dc.identifier.citation | Erida Gjini, M. Gabriela M. Gomes, Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure, Epidemics, Volume 14, March 2016, Pages 71-82, ISSN 1755-4365, http://dx.doi.org/10.1016/j.epidem.2015.11.001. | pt_PT |
dc.identifier.doi | 10.1016/j.epidem.2015.11.001 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.7/565 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsivier Science BV | pt_PT |
dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S1755436515000948 | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
dc.subject | Vaccination model | pt_PT |
dc.subject | Strain replacement | pt_PT |
dc.subject | Co-infection | pt_PT |
dc.subject | Competition | pt_PT |
dc.subject | ODE parameter inference | pt_PT |
dc.title | Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 82 | pt_PT |
oaire.citation.startPage | 71 | pt_PT |
oaire.citation.title | Epidemics | pt_PT |
oaire.citation.volume | 14 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: